Enhancement of the efficacy of mesenchymal stem cells in the treatment of ischemic diseases
Ischemic diseases refer to a wide range of diseases caused by reduced blood flow and a subsequently deficient oxygen and nutrient supply. The pathogenesis of ischemia is multifaceted and primarily involves inflammation, oxidative stress and an apoptotic response. Over the last decade, mesenchymal st...
Main Authors: | Ruixi Luo, Yanrong Lu, Jingping Liu, Jingqiu Cheng, Younan Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-01-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332218370847 |
Similar Items
-
Thrombin Preconditioning Enhances Therapeutic Efficacy of Human Wharton’s Jelly–Derived Mesenchymal Stem Cells in Severe Neonatal Hypoxic Ischemic Encephalopathy
by: Young Eun Kim, et al.
Published: (2019-05-01) -
Surfing the clinical trials of mesenchymal stem cell therapy in ischemic cardiomyopathy
by: Iman Razeghian-Jahromi, et al.
Published: (2021-06-01) -
Three-dimensional cultured mesenchymal stem cells enhance repair of ischemic stroke through inhibition of microglia
by: Yuejiao Li, et al.
Published: (2021-06-01) -
Efficacy of mesenchymal stem cell therapy in systolic heart failure: a systematic review and meta-analysis
by: Mengkang Fan, et al.
Published: (2019-05-01) -
Application of mesenchymal stem cell sheet to treatment of ischemic heart disease
by: Dehua Chang, et al.
Published: (2021-07-01)